- Home
- CHRS vs SJT Comparison
CHRS vs SJT Comparison
Compare CHRS & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- SJT
- Stock Information
- Founded
- CHRS 2010
- SJT 1980
- Country
- CHRS United States
- SJT United States
- Employees
- CHRS 235
- SJT N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- SJT Oil & Gas Production
- Sector
- CHRS Health Care
- SJT Energy
- Exchange
- CHRS Nasdaq
- SJT Nasdaq
- Market Cap
- CHRS 134.4M
- SJT 212.1M
- IPO Year
- CHRS 2014
- SJT N/A
- Fundamental
- Price
- CHRS $1.22
- SJT $4.00
- Analyst Decision
- CHRS Strong Buy
- SJT
- Analyst Count
- CHRS 4
- SJT 0
- Target Price
- CHRS $5.38
- SJT N/A
- AVG Volume (30 Days)
- CHRS 2.4M
- SJT 230.2K
- Earning Date
- CHRS 03-12-2025
- SJT 11-14-2024
- Dividend Yield
- CHRS N/A
- SJT 2.33%
- EPS Growth
- CHRS N/A
- SJT N/A
- EPS
- CHRS N/A
- SJT 0.19
- Revenue
- CHRS $304,340,000.00
- SJT $11,031,594.00
- Revenue This Year
- CHRS $2.47
- SJT N/A
- Revenue Next Year
- CHRS N/A
- SJT N/A
- P/E Ratio
- CHRS N/A
- SJT $21.16
- Revenue Growth
- CHRS 44.19
- SJT N/A
- 52 Week Low
- CHRS $0.66
- SJT $3.21
- 52 Week High
- CHRS $2.87
- SJT $5.81
- Technical
- Relative Strength Index (RSI)
- CHRS 44.03
- SJT 41.94
- Support Level
- CHRS $1.03
- SJT $3.96
- Resistance Level
- CHRS $1.23
- SJT $4.30
- Average True Range (ATR)
- CHRS 0.13
- SJT 0.16
- MACD
- CHRS -0.02
- SJT -0.05
- Stochastic Oscillator
- CHRS 38.89
- SJT 5.42
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.